DE1470151A1 - Verfahren zur Herstellung von neuen heterocyclischen Aminen - Google Patents
Verfahren zur Herstellung von neuen heterocyclischen AminenInfo
- Publication number
- DE1470151A1 DE1470151A1 DE19581470151 DE1470151A DE1470151A1 DE 1470151 A1 DE1470151 A1 DE 1470151A1 DE 19581470151 DE19581470151 DE 19581470151 DE 1470151 A DE1470151 A DE 1470151A DE 1470151 A1 DE1470151 A1 DE 1470151A1
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- heterocyclic amines
- quaternary ammonium
- formula
- ammonium compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68484857A | 1957-09-19 | 1957-09-19 | |
US71039158A | 1958-01-22 | 1958-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1470151A1 true DE1470151A1 (de) | 1969-04-30 |
Family
ID=27103445
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19581470151 Pending DE1470151A1 (de) | 1957-09-19 | 1958-02-28 | Verfahren zur Herstellung von neuen heterocyclischen Aminen |
DE19581470152 Pending DE1470152A1 (de) | 1957-09-19 | 1958-02-28 | Verfahren zur Herstellung von heterocyclischen Aminen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19581470152 Pending DE1470152A1 (de) | 1957-09-19 | 1958-02-28 | Verfahren zur Herstellung von heterocyclischen Aminen |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE565262A (US08088816-20120103-C00036.png) |
DE (2) | DE1470151A1 (US08088816-20120103-C00036.png) |
GB (1) | GB836083A (US08088816-20120103-C00036.png) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3366389A (en) * | 1988-03-25 | 1989-10-16 | Marion Laboratories, Inc. | Piperidine ring modified phencyclidine analogs as anticonvulsants |
US10583171B2 (en) | 2015-11-30 | 2020-03-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | NMDAR antagonists for the treatment of diseases associated with angiogenesis |
-
0
- BE BE565262D patent/BE565262A/xx unknown
-
1958
- 1958-02-27 GB GB641558A patent/GB836083A/en not_active Expired
- 1958-02-28 DE DE19581470151 patent/DE1470151A1/de active Pending
- 1958-02-28 DE DE19581470152 patent/DE1470152A1/de active Pending
Also Published As
Publication number | Publication date |
---|---|
DE1470152A1 (de) | 1969-04-30 |
GB836083A (en) | 1960-06-01 |
BE565262A (US08088816-20120103-C00036.png) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1543715C3 (de) | Basisch substituierte Phthalanderivate und deren pharmakologisch verträgliche Säureadditionssalze sowie Verfahren zu deren Herstellung | |
DE2502397A1 (de) | Guanidinderivate, ein verfahren zu deren herstellung sowie arzneimittel | |
DE3445339A1 (de) | 3,3-disubstituierte 1-(phenylamino)-guanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
DE3009071A1 (de) | 2-isopropylaminopyrimidinhydroxyderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
DE2167193C2 (de) | 4-(4-Hydroxypiperidino)-N,N,3-trimethyl-2,2-diphenylbutyramide und Verfahren zu ihrer Herstellung | |
DE1470151A1 (de) | Verfahren zur Herstellung von neuen heterocyclischen Aminen | |
DE2724478C2 (de) | 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE3025238A1 (de) | Basische cycloalkanonoximaether, verfahren zur herstellung derselben und diese enthaltende arzneimittel | |
DE2730593A1 (de) | Neue aminoalkoxybenzofurane, verfahren zur herstellung derselben und diese enthaltende pharmazeutische mittel | |
DE1141996B (de) | Verfahren zur Herstellung von heterocyclischen sekundaeren Aminen | |
DE1545961A1 (de) | Verfahren zur Herstellung von gamma-Picolylderivaten | |
DE1217396B (de) | Verfahren zur Herstellung von 1 - (Thienyl-21) - l-oxo-2-amino-propanen | |
DE1445636A1 (de) | Alkylenimine | |
DE2534963A1 (de) | Piperazino-pyrimidine und diese verbindungen enthaltende arzneimittel | |
DE2065426C3 (US08088816-20120103-C00036.png) | ||
DE1445415C3 (de) | Substituierte Imidazolidinone, ihre therapeutisch verträglichen Salze und Verfahren zu ihrer Herstellung | |
CH660004A5 (de) | Basische oximaether. | |
DE2423725A1 (de) | 5-phenyl-4-oxo-delta hoch 2,alphathiazolidinessigsaeureester | |
DE2520937A1 (de) | Neue 1,4-benzodiazepinderivate | |
DE2139099B2 (de) | l-Methyl-2-(p-methyl- a -phenylbenzyloxymethyl)piperidin, seine Salze mit Säuren und quartäre Ammoniumsalze, Verfahren zur Herstellung dieser Verbindungen und Arzneimittel | |
DE2518289C3 (de) | Basisch substituierte Hexahydrodibenzofuran-3-one und deren Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE2737241A1 (de) | 1, 2, 3, 4, 5, 6-hexahydro-1,6-methano-3-benzazocine | |
AT220144B (de) | Verfahren zur Herstellung von neuen tertiären Aminen, sowie deren Säureadditions- und quaternären Ammoniumsalzen | |
DE1111176B (de) | Verfahren zur Herstellung von therapeutisch wertvollen N-dialiphatisch substituierten 1-Phenylcyclohexylaminen bzw. deren Saeureadditionssalzen | |
AT256874B (de) | Verfahren zur Herstellung neuer heterocyclischer Guanidinverbindungen bzw. ihrer Säureadditionssalze |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SH | Request for examination between 03.10.1968 and 22.04.1971 |